The DOI matches its Crossref record; 560 of the 560 references it cites were found in a registry or an index.
Antibody Structure and Function: The Basis for Engineering Therapeutics
Open accessAbstract
Antibodies and antibody-derived macromolecules have established themselves as the mainstay in protein-based therapeutic molecules (biologics). Our knowledge of the structure–function relationships of antibodies provides a platform for protein engineering that has been exploited to generate a wide range of biologics for a host of therapeutic indications. In this review, our basic understanding of the antibody structure is described along with how that knowledge has leveraged the engineering of antibody and antibody-related therapeutics having the appropriate antigen affinity, effector function, and biophysical properties. The platforms examined include the development of antibodies, antibody fragments, bispecific antibody, and antibody fusion products, whose efficacy and manufacturability can be improved via humanization, affinity modulation, and stability enhancement. We also review the design and selection of binding arms, and avidity modulation. Different strategies of preparing bispecific and multispecific molecules for an array of therapeutic applications are included.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Berman, H. M. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.1.235 · Cited by 40,196
Signal transduction by receptors with tyrosine kinase activity
Ullrich, A., & Schlessinger, J. (1990) · Cell · doi:10.1016/0092-8674(90)90801-k · Cited by 5,435
Cancer immunotherapy comes of age
Mellman, I., Coukos, G., & Dranoff, G. (2011) · Nature · doi:10.1038/nature10673 · Cited by 3,893
Trastuzumab emtansine for HER2-positive advanced breast cancer
Verma, S., Miles, D., Gianni, L., Krop, I. E., Welslau, M., Baselga, J., Pegram, M., Oh, D.-Y., Diéras, V., Guardino, E., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1209124 · Cited by 3,834
Molecular mechanisms of T cell co-stimulation and co-inhibition
Chen, L., & Flies, D. B. (2013) · Nature Reviews Immunology · doi:10.1038/nri3405 · Cited by 3,114
FcRn: the neonatal Fc receptor comes of age
Roopenian, D. C., & Akilesh, S. (2007) · Nature Reviews Immunology · doi:10.1038/nri2155 · Cited by 2,346
The hydrolysis of rabbit γ-globulin and antibodies with crystalline papain
Porter, R. R. (1959) · Biochemical Journal · doi:10.1042/bj0730119 · Cited by 2,308
Nanobodies: natural single-domain antibodies
Muyldermans, S. (2013) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-063011-092449 · Cited by 2,304
The atomic structure of protein-protein recognition sites 1 1Edited by A. R. Fersht
Conte, L. L., Chothia, C., & Janin, J. (1999) · Journal of Molecular Biology · doi:10.1006/jmbi.1998.2439 · Cited by 1,964
Humanization of an anti-p185HER2 antibody for human cancer therapy.
Carter, P., Presta, L., Gorman, C. M., Ridgway, J. B., Henner, D., Wong, W. L., Rowland, A. M., Kotts, C., Carver, M. E., & Shepard, H. M. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.10.4285 · Cited by 1,918
Cited by
Olsen, T. H., Boyles, F., & Deane, C. M. (2022) · Protein Science · doi:10.1002/pro.4205 · Cited by 319
ImmuneBuilder: Deep-Learning models for predicting the structures of immune proteins
Abanades, B., Wong, W. K., Boyles, F., Georges, G., Bujotzek, A., & Deane, C. M. (2023) · Communications Biology · doi:10.1038/s42003-023-04927-7 · Cited by 298
Avidity in antibody effector functions and biotherapeutic drug design
Oostindie, S. C., Lazar, G. A., Schuurman, J., & Parren, P. W. H. I. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-022-00501-8 · Cited by 298
AFsample: improving multimer prediction with AlphaFold using massive sampling
Wallner, B. (2023) · Bioinformatics · doi:10.1093/bioinformatics/btad573 · Cited by 164
ABlooper: fast accurate antibody CDR loop structure prediction with accuracy estimation
Abanades, B., Georges, G., Bujotzek, A., & Deane, C. M. (2022) · Bioinformatics · doi:10.1093/bioinformatics/btac016 · Cited by 157
Delidakis, G., Kim, J. E., George, K., & Georgiou, G. (2022) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-082721-024500 · Cited by 87
Challenges in antibody structure prediction
Fernández-Quintero, M. L., Kokot, J., Waibl, F., Fischer, A.-L. M., Quoika, P. K., Deane, C. M., & Liedl, K. R. (2023) · mAbs · doi:10.1080/19420862.2023.2175319 · Cited by 55
Ultrasmall-in-Nano: Why Size Matters
Mellor, R. D., & Uchegbu, I. F. (2022) · Nanomaterials · doi:10.3390/nano12142476 · Cited by 51
Polonsky, K., Pupko, T., & Freund, N. T. (2023) · The Journal of Immunology · doi:10.4049/jimmunol.2300150 · Cited by 41
Splenic B cell-targeting lipid nanoparticles for safe and effective mRNA vaccine delivery
Suzuki, Y., Yakuwa, M., Sato, M., Samaridou, E., Beck-Broichsitter, M., Maeki, M., Tokeshi, M., Yamada, Y., Harashima, H., & Sato, Y. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.113687 · Cited by 37
Simultaneous prediction of antibody backbone and side-chain conformations with deep learning
Akpinaroglu, D., Ruffolo, J. A., Mahajan, S. P., & Gray, J. J. (2022) · PLOS ONE · doi:10.1371/journal.pone.0258173 · Cited by 21
Predicting the conformational flexibility of antibody and T-cell receptor CDRs
Spoendlin, F. C., Fernández-Quintero, M. L., Raghavan, S. S. R., Turner, H. L., Gharpure, A., Loeffler, J. R., Wong, W. K., Bujotzek, A., Georges, G., Ward, A. B., et al. (2025) · doi:10.1101/2025.03.19.644119 · Cited by 20
Spoendlin, F. C., Fernández-Quintero, M. L., Raghavan, S. S. R., Turner, H. L., Gharpure, A., Loeffler, J. R., Wong, W. K., Bujotzek, A., Georges, G., Ward, A. B., et al. (2025) · Nature Machine Intelligence · doi:10.1038/s42256-025-01131-6 · Cited by 20
A conformational fingerprint for amyloidogenic light chains
(2024) · doi:10.7554/elife.102002 · Cited by 9
A conformational fingerprint for amyloidogenic light chains
Paissoni, C., Puri, S., Broggini, L., Sriramoju, M. K., Maritan, M., Russo, R., Speranzini, V., Ballabio, F., Nuvolone, M., Merlini, G., et al. (2024) · doi:10.1101/2024.07.12.603200 · Cited by 4
Deep geometric framework to predict antibody–antigen binding affinity
(2025) · doi:10.1016/j.jsb.2025.108257 · Cited by 3
Tikhonov, S., Babich, O., Sukhikh, S., Tikhonova, N., & Chernukha, I. (2025) · Journal of Applied Biology & Biotechnology · doi:10.7324/jabb.2025.219617 · Cited by 2
“For the studied peptide, it is 0.869 with an optimal value for medicinal substances ranging from 0.5 to 3 [28].”
Influential
Metadata
- Authors
- Chiu, M. L., Goulet, D. R., Teplyakov, A., & Gilliland, G. L.
- Venue
- Antibodies
- Publisher
- MDPI AG
- Published
- 2019-12-03
- Volume
- 8
- Issue
- 4
- Pages
- 55
- ISSN
- 2073-4468 (ISSN-L)
- OpenAlex
- W2993866869
- Cited by
- 638
- References
- 560
- FWCI
- 28.20
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.